Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-05-16 Purchase |
2022-05-16 8:48 pm |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
20,000 | $8.1644 | $163,288 | 807,921 (Indirect Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 8:45 pm |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
20,500 | $7.4066 | $151,835 | 65,319 (Indirect Direct) |
View |
| 2022-05-13 Purchase |
2022-05-16 8:43 pm |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
6,000 | $0 | $0 | 26,000 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-16 8:39 pm |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
12,500 | $8 | $100,000 | 12,500 (Direct) |
View |
| 2022-03-14 Sale |
2022-03-16 8:10 pm |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
18 | $19 | $342 | 7,459,286 (Direct) |
View |
| 2021-11-04 Sale |
2021-11-08 06:04 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
1,000,001 | $20.85 | $20,850,019 | 7,459,304 (Direct) |
View |
| 2021-10-07 Sale |
2021-10-08 6:28 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
18,000 | $32.58 | $586,395 | 1,211,756 (Indirect) |
View |
| 2021-09-21 Sale |
2021-09-23 8:37 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
18,000 | $32.63 | $587,351 | 1,229,756 (Indirect) |
View |
| 2021-08-16 Sale |
2021-08-18 5:31 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
18,000 | $31.25 | $562,538 | 1,247,449 (Indirect) |
View |
| 2021-07-07 Sale |
2021-07-09 06:09 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
2,609 | $35.05 | $91,445 | 871,305 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-06 06:10 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
8,326 | $35.16 | $292,727 | 873,914 (Direct) |
View |
| 2021-06-28 Sale |
2021-06-29 8:43 pm |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
40,000 | $34.05 | $1,361,941 | 1,261,048 (Indirect) |
View |
| 2021-06-25 Sale |
2021-06-29 06:44 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
24,501 | $35.49 | $869,427 | 882,240 (Direct) |
View |
| 2021-06-23 Sale |
2021-06-25 07:27 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
11,048 | $35.14 | $388,199 | 906,741 (Direct) |
View |
| 2021-06-21 Sale |
2021-06-23 06:15 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
9,394 | $35.31 | $331,671 | 917,789 (Direct) |
View |
| 2021-06-17 Sale |
2021-06-21 06:10 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
8,703 | $35.11 | $305,571 | 927,183 (Direct) |
View |
| 2021-06-14 Sale |
2021-06-16 06:06 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
2,826 | $35.06 | $99,080 | 935,886 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-11 06:09 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
3,293 | $35.19 | $115,883 | 938,712 (Direct) |
View |
| 2021-06-07 Sale |
2021-06-09 06:41 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
2,364 | $35.05 | $82,853 | 942,005 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-04 06:23 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
4,300 | $35.18 | $151,274 | 944,369 (Direct) |
View |
| 2021-05-28 Sale |
2021-06-02 06:08 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
20,116 | $35.96 | $723,434 | 948,669 (Direct) |
View |
| 2021-05-26 Sale |
2021-05-28 06:11 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
20,811 | $36.84 | $766,700 | 968,785 (Direct) |
View |
| 2021-05-24 Sale |
2021-05-26 09:42 am |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
21,541 | $35.93 | $773,889 | 989,596 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-19 Option Award |
2022-05-20 5:17 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
12,000 | $0 | 38,000 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 5:14 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
12,000 | $0 | 77,319 (Direct) |
View |
| 2022-04-25 Option Award |
2022-04-26 5:21 pm |
N/A 2032-04-24 |
Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director |
20,000 | $0 | 20,000 (Direct) |
View |
| 2022-04-05 Option Award |
2022-04-06 8:50 pm |
N/A 2032-04-04 |
Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2022-03-14 Exercise |
2022-03-16 8:10 pm |
2019-10-29 2029-05-07 |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
7,359,304 | $0 | 7,459,286 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 6:52 pm |
N/A 2032-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer |
117,000 | $0 | 885,421 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 6:49 pm |
N/A 2032-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Guzzo Anthony J. VP, Chief Accounting Officer |
36,000 | $0 | 38,863 (Direct) |
View |
| 2022-01-19 Option Award |
2022-01-21 6:47 pm |
N/A 2032-01-18 |
Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive |
247,500 | $0 | 250,809 (Direct) |
View |
| 2021-11-04 Exercise |
2021-11-08 06:04 am |
2019-10-29 2029-05-07 |
Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner |
228,696 | $0 | 7,459,304 (Direct) |
View |
| 2021-07-13 Option Award |
2021-07-14 4:42 pm |
N/A 2031-07-12 |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
7,500 | $0 | 7,500 (Direct) |
View |
Ownership |
2021-06-11 4:44 pm |
N/A N/A |
Phathom Pharmaceuticals Inc. | PHAT | Guzzo Anthony J. VP, Chief Accounting Officer |
0 | $0 | 94,554 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-24 5:55 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-24 5:50 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-24 5:44 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-24 5:39 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | COLA MICHAEL F Director |
12,500 | $0 | 12,500 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-24 5:35 pm |
N/A 2031-05-20 |
Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director |
12,500 | $0 | 12,500 (Direct) |
View |